{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:28:05Z","timestamp":1790692085029,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00428-020-02800-0","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T21:02:10Z","timestamp":1587070930000},"page":"565-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Complement activation is associated with crescent formation in IgA nephropathy"],"prefix":"10.1007","volume":"477","author":[{"given":"Hiroe","family":"Itami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Samejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Kitada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinta","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiho","family":"Ohbayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"2800_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.krcp.2016.09.001","volume":"35","author":"Y Tomino","year":"2016","unstructured":"Tomino Y (2016) Diagnosis and treatment of patients with IgA nephropathy in Japan. Kidney Res Clin Pract 35:197\u2013203","journal-title":"Kidney Res Clin Pract"},{"key":"2800_CR2","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J, IgAN classification working group of the international IgA nephropathy network and the renal pathology society, conference participants (2017) Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int 91:1014\u20131021","journal-title":"Kidney Int"},{"key":"2800_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0272-6386(88)80042-8","volume":"12","author":"RJ Wyatt","year":"1988","unstructured":"Wyatt RJ, Julian BA (1988) Activation of complement in IgA nephropathy. Am J Kidney Dis 12:437\u2013442","journal-title":"Am J Kidney Dis"},{"key":"2800_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-immunol-030409-101250","volume":"28","author":"C Kemper","year":"2010","unstructured":"Kemper C, Atkinson JP, Hourcade DE, Kemper C, Atkinson JP, Hourcade DE (2010) Properdin: emerging roles of a pattern-recognition molecule. Annu Rev Immunol 28:131\u2013155","journal-title":"Annu Rev Immunol"},{"key":"2800_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0161-5890(01)00038-4","volume":"38","author":"SV Petersen","year":"2001","unstructured":"Petersen SV, Thiel S, Jensenius JC (2001) The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 38:133\u2013149","journal-title":"Mol Immunol"},{"key":"2800_CR6","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ki.1987.72","volume":"31","author":"EW Rauterberg","year":"1987","unstructured":"Rauterberg EW, Lieberknecht HM, Wingen AM, Ritz E (1987) Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney Int 31:820\u2013829","journal-title":"Kidney Int"},{"key":"2800_CR7","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1681\/ASN.2005090923","volume":"17","author":"A Roos","year":"2006","unstructured":"Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR (2006) Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17:1724\u20131734","journal-title":"J Am Soc Nephrol"},{"key":"2800_CR8","doi-asserted-by":"publisher","unstructured":"Ohsawa I, Ishii M, Ohi H, Tomino Y (2012) Pathological scenario with the mannose-binding lectin in patients with IgA nephropathy. J Biomed Biotechnol 2012:476739. https:\/\/doi.org\/10.1155\/2012\/476739","DOI":"10.1155\/2012\/476739"},{"key":"2800_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/cei.12154","volume":"174","author":"LL Liu","year":"2013","unstructured":"Liu LL, Liu N, Chen Y, Wang LN, Jiang Y, Wang J, Li XL, Yao L, Fan QL (2013) Glomerular mannose-binding lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathy. Clin Exp Immunol 174:152\u2013160","journal-title":"Clin Exp Immunol"},{"key":"2800_CR10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/ndt\/gfn563","volume":"24","author":"M Espinosa","year":"2009","unstructured":"Espinosa M, Ortega R, Gomez-Carrasco JM, L\u00f3pez-Rubio F, L\u00f3pez-Andreu M, L\u00f3pez-Oliva MO et al (2009) Mesangial C4d deposition: a new prognostic factor in IgA nephropathy. Nephrol Dial Transplant 24:886\u2013891","journal-title":"Nephrol Dial Transplant"},{"key":"2800_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0272-6386(88)80056-8","volume":"11","author":"KN Lai","year":"1988","unstructured":"Lai KN, Lai FM, Lo ST, Lam CW (1988) Light chain composition of IgA in IgA nephropathy. Am J Kidney Dis 11:425\u2013429","journal-title":"Am J Kidney Dis"},{"key":"2800_CR12","first-page":"66","volume":"33","author":"S Suzuki","year":"1990","unstructured":"Suzuki S, Kobayashi H, Sato H, Arakawa M (1990) Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy. Clin Nephrol 33:66\u201371","journal-title":"Clin Nephrol"},{"key":"2800_CR13","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, Collaborators developing the Japanese equation for estimated GFR (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982\u2013992","journal-title":"Am J Kidney Dis"},{"key":"2800_CR14","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1093\/ndt\/13.8.1984","volume":"13","author":"M Endo","year":"1998","unstructured":"Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M, Fujita T (1998) Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant 13:1984\u20131990","journal-title":"Nephrol Dial Transplant"},{"key":"2800_CR15","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.ajpath.2012.06.038","volume":"181","author":"A Hashimoto","year":"2012","unstructured":"Hashimoto A, Suzuki Y, Suzuki H, Ohsawa I, Brown R, Hall S, Tanaka Y, Novak J, Ohi H, Tomino Y (2012) Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes. Am J Pathol 181:1338\u20131347","journal-title":"Am J Pathol"},{"key":"2800_CR16","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/ndt\/15.10.1506","volume":"15","author":"MR Daha","year":"2000","unstructured":"Daha MR, van Kooten C (2000) Is there a role for locally produced complement in renal disease? Nephrol Dial Transplant 15:1506\u20131509","journal-title":"Nephrol Dial Transplant"},{"key":"2800_CR17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2215\/CJN.09710913","volume":"9","author":"M Espinosa","year":"2014","unstructured":"Espinosa M, Ortega R, S\u00e1nchez M, Segarra A, Salcedo MT, Gonz\u00e1lez F, Camacho R, Valdivia MA, Cabrera R, L\u00f3pez K, Pinedo F, Gutierrez E, Valera A, Leon M, Cobo MA, Rodriguez R, Ballar\u00edn J, Arce Y, Garc\u00eda B, Mu\u00f1oz MD, Praga M, Spanish Group for Study of Glomerular Diseases (GLOSEN) (2014) Association of C4d deposition with clinical outcomes in IgA nephropathy. Clin J Am Soc Nephrol 9:897\u2013904","journal-title":"Clin J Am Soc Nephrol"},{"key":"2800_CR18","first-page":"3299","volume":"7","author":"OZ Sahin","year":"2014","unstructured":"Sahin OZ, Yavas H, Tasl\u0131 F, Gibyeli DG, Ersoy R, Uzum A et al (2014) Prognostic value of glomerular C4d staining in patients with IgA nephritis. Int J Clin Exp Pathol 7:3299\u20133304","journal-title":"Int J Clin Exp Pathol"},{"key":"2800_CR19","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3109\/0886022X.2015.1077319","volume":"37","author":"C Heybeli","year":"2015","unstructured":"Heybeli C, Unlu M, Yildiz S, \u00c7avdar C, Sarioglu S, Camsari T (2015) IgA nephropathy: association of C4d with clinical and histopathological findings and possible role of IgM. Ren Fail 37:1464\u20131469","journal-title":"Ren Fail"},{"key":"2800_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2215\/CJN.02530317","volume":"13","author":"A Segarra","year":"2018","unstructured":"Segarra A, Romero K, Agraz I, Ramos N, Madrid A, Carnicer C, Jatem E, Vilalta R, Lara LE, Ostos E, Valtierra N, Jaramillo J, Arredondo KV, Ariceta G, Martinez C (2018) Mesangial C4d deposits in early IgA nephropathy. Clin J Am Soc Nephrol 13:258\u2013264","journal-title":"Clin J Am Soc Nephrol"},{"key":"2800_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ekir.2017.11.015","volume":"3","author":"NR Medjeral-Thomas","year":"2018","unstructured":"Medjeral-Thomas NR, Troldborg A, Constantinou N, Lomax-Browne HJ, Hansen AG, Willicombe M, Pusey CD, Cook HT, Thiel S, Pickering MC (2018) Progressive IgA nephropathy is associated with low circulating mannan-binding lectin-associated serine protease-3 (MASP-3) and increased glomerular factor H-related protein-5 (FHR5) deposition. Kidney Int Rep 3:426\u2013438","journal-title":"Kidney Int Rep"},{"key":"2800_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000496059","volume":"49","author":"P Chandra","year":"2019","unstructured":"Chandra P (2019) C4d in native glomerular diseases. Am J Nephrol 49:81\u201392","journal-title":"Am J Nephrol"},{"key":"2800_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1471-2369-12-64","volume":"12","author":"K Onda","year":"2011","unstructured":"Onda K, Ohsawa I, Ohi H, Tamano M, Mano S, Wakabayashi M et al (2011) Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function. BMC Nephrol 12:64","journal-title":"BMC Nephrol"},{"key":"2800_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/00365590801943241","volume":"42","author":"M Stangou","year":"2008","unstructured":"Stangou M, Alexopoulos E, Pantzaki A, Leonstini M, Memmos D (2008) C5b-9 glomerular deposition and tubular \u03b13\u03b21-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy. Scand J Urol Nephrol 42:373\u2013380","journal-title":"Scand J Urol Nephrol"},{"key":"2800_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3389\/fimmu.2019.00504","volume":"10","author":"DV Rizk","year":"2019","unstructured":"Rizk DV, Maillard N, Julian BA, Knoppova B, Green TJ, Novak J et al (2019) The emerging role of complement proteins as a target for therapy of IgA nephropathy. Front Immunol 10:504","journal-title":"Front Immunol"},{"key":"2800_CR26","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.transproceed.2017.02.044","volume":"49","author":"AL Herzog","year":"2017","unstructured":"Herzog AL, Wanner C, Amann K, Lopau K (2017) First treatment of relapsing rapidly progressive IgA nephropathy with Eculizumab after living kidney donation: a case report. Transplant Proc 49:1574\u20131577","journal-title":"Transplant Proc"},{"key":"2800_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10157-018-1619-6","volume":"23","author":"R Katafuchi","year":"2019","unstructured":"Katafuchi R, Nagae H, Masutani K, Tsuruya K, Mitsuiki K (2019) Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy. Clin Exp Nephrol 23:169\u2013181","journal-title":"Clin Exp Nephrol"},{"key":"2800_CR28","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1681\/ASN.2014101000","volume":"26","author":"N Maillard","year":"2015","unstructured":"Maillard N, Wyatt RJ, Julian BA, Kiryluk K, Gharavi A, Fremeaux-Bacchi V et al (2015) Current understanding of the role of complement in IgA nephropathy. J Am Soc Nephrol 26:1503\u20131512","journal-title":"J Am Soc Nephrol"},{"key":"2800_CR29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2215\/CJN.07260713","volume":"9","author":"PA Canetta","year":"2014","unstructured":"Canetta PA, Kiryluk K, Appel GB (2014) Glomerular diseases: emerging tests and therapies for IgA nephropathy. Clin J Am Soc Nephrol 9:617\u2013625","journal-title":"Clin J Am Soc Nephrol"},{"key":"2800_CR30","doi-asserted-by":"publisher","first-page":"101331","DOI":"10.1016\/j.smim.2019.101331","volume":"45","author":"K Kaartinen","year":"2019","unstructured":"Kaartinen K, Safa A, Kotha S, Ratti G, Meri S (2019) Complement dysregulation in glomerulonephritis. Semin Immunol 45:101331","journal-title":"Semin Immunol"},{"key":"2800_CR31","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/ndt\/gfv288","volume":"32","author":"M Hilhorst","year":"2017","unstructured":"Hilhorst M, van Paassen P, van Rie H, Bijnens N, Heerings-Rewinkel P, van Breda VP et al (2017) Complement in ANCA-associated glomerulonephritis. Nephrol Dial Transplant 32:1302\u20131313","journal-title":"Nephrol Dial Transplant"},{"key":"2800_CR32","doi-asserted-by":"publisher","first-page":"e91250","DOI":"10.1371\/journal.pone.0091250","volume":"9","author":"R Ma","year":"2014","unstructured":"Ma R, Cui Z, Hu SY, Jia XY, Yang R, Zheng X et al (2014) The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease. PLoS One 9:e91250","journal-title":"PLoS One"},{"key":"2800_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/ajcp\/85.5.548","volume":"85","author":"KN Lai","year":"1986","unstructured":"Lai KN, Chan KW, Mac-Moune F, Ho CP, Yan KW, Lam CW et al (1986) The immunochemical characterization of the light chains in the mesangial IgA deposits in IgA nephropathy. Am J Clin Pathol 85:548\u2013551","journal-title":"Am J Clin Pathol"},{"key":"2800_CR34","doi-asserted-by":"publisher","first-page":"c18","DOI":"10.1159\/000324180","volume":"119","author":"SH Nasr","year":"2011","unstructured":"Nasr SH, D'Agati VD (2011) IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract 119:c18\u2013c25","journal-title":"Nephron Clin Pract"},{"key":"2800_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12967-018-1488-5","volume":"16","author":"X Zhang","year":"2018","unstructured":"Zhang X, Shi S, Ouyang Y, Yang M, Shi M, Pan X et al (2018) A validation study of crescents in predicting ESRD in patients with IgA nephropathy. J Transl Med 16:115","journal-title":"J Transl Med"},{"key":"2800_CR36","doi-asserted-by":"publisher","first-page":"e6190","DOI":"10.1097\/MD.0000000000006190","volume":"96","author":"W Zhang","year":"2017","unstructured":"Zhang W, Zhou Q, Hong L, Chen W, Yang S, Yang Q et al (2017) Clinical outcomes of IgA nephropathy patients with different proportions of crescents. Medicine (Baltimore) 96:e6190","journal-title":"Medicine (Baltimore)"},{"key":"2800_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000497808","volume":"44","author":"S Park","year":"2019","unstructured":"Park S, Baek CH, Park SK, Kang HG, Hyun HS, Park E, Han SH, Ryu DR, Kim DK, Oh KH, Joo KW, Kim YS, Moon KC, Chin HJ, Lee H (2019) Clinical significance of crescent formation in IgA nephropathy - a multicenter validation study. Kidney Blood Press Res 44:22\u201332","journal-title":"Kidney Blood Press Res"},{"key":"2800_CR38","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/HYPERTENSIONAHA.118.11210","volume":"73","author":"CC Ruan","year":"2019","unstructured":"Ruan CC, Gao PJ (2019) Role of complement-related inflammation and vascular dysfunction in hypertension. Hypertension. 73:965\u2013971","journal-title":"Hypertension."}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-020-02800-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T23:53:50Z","timestamp":1618530830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-020-02800-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["2800"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-02800-0","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"assertion":[{"value":"1 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of Nara Medical University and conducted in accordance with the tenets of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}